Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.
Calgary
Joined January 2022
- Tweets22
- Following62
- Followers123
- Likes3
Ocumetics has completed the third and final tranche of its previously announced private placement, bringing total gross proceeds from the offering to $3,110,130.
Full - Release Here - opportunity.ocumetics.com/oc…
Built to Move Like the Eye
Your natural lens doesn’t stay fixed—it adapts.
The Ocumetics Lens is designed to do the same.
Vision designed to behave like nature intended.
#Biotech #FutureMedicine #Innovation
ocumetics.com
Invest In The Next Generation Of Vision Technology
The Ocumetics Lens Is Designed to Restore Natural Sight
TSX-V:OTC | OCTQB: OTCFF
Learn More - ocumetics.com
Focus on what matters to you discover the opportunity behind the innovation.
Discover Ocumetics - opportunity.ocumetics.com
TSX-V:OTC | OCTQB: OTCFF
The Reality of Today’s Solutions
Glasses. Contacts. Laser surgery.
Each solution improves vision—but none truly restore how the eye naturally works.
Discover Ocumetics - ocumetics.com
#EyeCare #Innovation #NextGenMedicine
A Market Measured in Billions
The opportunity is as significant as the problem.
• 24M+ cataract surgeries annually
• $6.4B projected IOL market
Where necessity meets innovation—markets are created.
Learn More - opportunity.ocumetics.com
#HealthcareMarkets #Growth #MedTech
A Growing Global Challenge
• 2.2 billion people require vision correction today
• That number continues to rise as populations age
This isn’t just a healthcare challenge. It’s one of the largest unmet needs in modern medicine.
Learn More - ocumetics.com
What if vision correction wasn’t something you managed—but something you solved?
Ocumetics is developing a next-generation intraocular lens designed to restore clear vision across all distances. Learn More - ocumetics.com
#FutureOfVision #MedTech #Innovation
Ocumetics Technology Corp. advances its next-gen intraocular lens—improving reliability, performance, and scalability by eliminating fluid-based systems.
With precision engineering + Group 2 surgeries ahead, momentum is building. - bit.ly/4c4xzLx
The ASCRS annual meeting is one of the world’s leading gatherings of ophthalmic surgeons, researchers, and medical technology companies. Click here to learn more - annualmeeting.ascrs.org.
Huge thanks to CEM for an amazing conference. The 1:1 meetings were engaging and a fantastic way to connect with the capital markets community. #WhistlerCapitalEvent #CEM #CapitalMarkets #InvestorMeetings #Ocumetics
FLASHBACK FRIDAY - ICYMI
Ocumetics Webinar 02 04 26 - First-In-Human Study Three-Month Results Update
Watch Video - youtu.be/E_5egT5PRxo
Listen To Podcast - howardgroupinc.com/podcasts/
$otc #ocumetics #podcasts #howardgroupinc #ir #tsx
TSX-V:OTC | OCTQB: OTCFF | FSE: 2QB0
Dean Burns, President and CEO of Ocumetics, will be attending investor meetings at the CEM 16th Annual Whistler Capital Event hosted at the beautiful Fairmont Chateau Whistler, BC. @capitalevent #tsx #tmx $otc
“These first-in-human results are exactly what we were aiming to demonstrate at this stage: safe implantation, reliable delivery, and strong visual outcomes,” said Dean Burns, President and CEO of Ocumetics. TSXV: OTC | OTCQB: OTCFF | FRA: 2QBO $OTC
From All Of Us @ocumetics
We Wish You A Merry Christmas & Happy New Year
#eyesight #christmas #accommodatingintraocularlens
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations - Read the full release - ocumetics.com
Ocumetics Technology Corp. - TSX.V: OTC retweeted
Can a lens replace your #glasses forever? @OcumeticsTech (TSXV: $OTC | OTCQB: $OTCFF | FRA: 2QBO) is betting on it.
Ocumetics is developing an advanced intraocular lens designed to work with the #eye’s own muscles, enabling users to see clearly from far to near without glasses or #contacts. The implications for the $158B #eyewear market could be massive.
Early clinical trials are showing functional distance #vision of 20/40 or better, with signs of near-vision improvement after just one month. Ocumetics is targeting a massive fast-growing market where 24 million #cataract surgeries are done globally each year, and the intraocular lens segment is projected to surpass $6B by 2030.
With decades of research behind its platform that could redefine how people see the world, Ocumetics earned its place as a Top 5 Pick at the 2025 CEM Muskoka.
Watch the video clip as @RyanIverson_ discusses why Ocumetics is gaining momentum with investors.
Want to be the first to access breakout companies before the broader market catches on? Subscribe to the Investor Breakout newsletter: bit.ly/4gj3yaY
__
@CapitalEvent @MarketOneMedia @FarhanLalani @NCurrie
Please see our disclaimer: bit.ly/4qur8b2
Ocumetics is pleased to announce it will be presenting at the Centurion One Capital 3rd Annual Bahamas Summit, a two day invitation only event taking place at the exclusive Rosewood Baha Mar Hotel from Oct 28th to Oct 29th, 2025, in Nassau, Bahamas. #Ocumetics #VisionInnovation
Ocumetics mentioned in Needham Report
Searching For The Holy Grail - Accommodating Intraocular Lens (AIOL) Deep Dive - LINK - needham.bluematrix.com/sells…
We’re heading to NYC! 🚀 Catch us at the Maxim Growth Summit (Oct 22–23, Hard Rock Hotel) — where top innovators and institutions unite to drive the next wave of growth. #Ocumetics #VisionInnovation